SCM
RDY icon

Shelton Capital Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Shelton Capital Management’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-28,500
Closed -$395K – 790
2026
Q1 		$395K Sell
28,500
-22,100
-44% -$308K 0.01% 422
2025
Q4 		$710K Buy
50,600
+8,000
+19% +$112K 0.01% 294
2025
Q3 		$596K Sell
42,600
-40,817
-49% -$587K 0.01% 315
2025
Q2 		$1.25M Sell
83,417
-680
-0.8% -$9.71K 0.03% 255
2025
Q1 		$1.11M Sell
84,097
-3,253
-4% -$44.9K 0.03% 264
2024
Q4 		$1.38M Buy
87,350
+300
+0.3% +$4.51K 0.03% 250
2024
Q3 		$1.38M Sell
87,050
-10,170
-10% -$164K 0.04% 260
2024
Q2 		$1.48M Sell
97,220
-7,235
-7% -$104K 0.04% 258
2024
Q1 		$1.53M Sell
104,455
-955
-0.9% -$13.9K 0.04% 262
2023
Q4 		$1.47M Buy
+105,410
New +$1.41M 0.05% 255
2023
Q3 		– Sell
-74,500
Closed -$940K – 734
2023
Q2 		$940K Buy
74,500
+42,000
+129% +$490K 0.03% 273
2023
Q1 		$370K Buy
+32,500
New +$351K 0.02% 386

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Shelton Capital Management's RDY Position: Q2 2026 in Review

Shelton Capital Management sold out of Dr. Reddy's Laboratories (RDY) in Q2 2026, closing a stake of 28,500 shares — an estimated $395K sold.

Shelton Capital Management first reported a position in RDY in Q1 2023 and held it in 12 quarters. The position peaked at $1.53M in Q1 2024. 239 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • Shelton Capital Management reported no remaining Dr. Reddy's Laboratories position as of Q2 2026 after selling out during the quarter.
  • Shelton Capital Management sold 28,500 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $395K.
  • Shelton Capital Management first reported a position in Dr. Reddy's Laboratories in Q1 2023 and held it in 12 quarters.
  • Shelton Capital Management's Dr. Reddy's Laboratories position peaked at $1.53M in Q1 2024.
  • 239 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Shelton Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.